First reported case of alloimmune fetal thrombocytopenia in primigravida

Authors

  • Leonardo Jiménez Fernández Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia
  • Alexander Céspedes Masis Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia
  • Kay-Uwe Sander Mangel Caja Costarricense del Seguro Social, Hospital Dr. Rafael A. Calderón Guardia

DOI:

https://doi.org/10.51481/amc.v56i4.860

Keywords:

Thrombocytopenia, yimmunology, fetus

Abstract

Fetal alloimmune thrombocytopenia is a potentially dangerous condition, which may lead to intracranial hemorrhage in the fetus or newborn. In the absence of screening programs, preventive measures are possible only in subsequent pregnancies of women with a child affected by such condition. There is controversy about the best intervention to reduce the risk of intracranial hemorrhage. Prenatal immunoglobulin and steroids treatment is currently recommended. The use of serial cordocentesis is not recommended. There are neither guidelines on how to treat a primigravida with this condition, such as the case presented here in, nor publications of similar cases.

Downloads

Download data is not yet available.

References

Peterson J, McFarland J, Curtis B, Aster R. Parallel Randomized Trials of RiskBased Therapy for Fetal Alloimmune Thrombocytopenia. Obstet Gynecol 2006; 107: 91-95.

Davoren A, Curtis BR, Aster RH, McFarland JG. Human platelet antigen-specific alloantibodies in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44: 1220-1225.

Turner ML, Bessos H, Fagge T, Harkness M, Rentoul F, Seymor J et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005; 45: 1945- 1956.

Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55.

Radder CM, Brand A, Kanhai HH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003; 84: 318-325.

Pacheco LD, Berkowitz R, Moise K, Bussel JD, McFarland JG, Saade GR. Fetal and Neonatal Alloimmune Thrombocytopenia. A Management Algorithm Based on Risk Stratification. Obstet Gynecol 2011; 118: 1157-1163.

Bussel JB, Berkowitz RL, Hung C, Kolb EA, Wissert M, Primiani A, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010;203:135.e1-14.

Silver RM, Porter TF, Branch DW, Esplin MS, Scott JR. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol 2000;182:1233-1238.

Overton TG, Duncan KR, Jolly M, Letsky E, Fisk N. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002; 186:826-831.

Downloads

Published

2014-10-01

Versions

Issue

Vol. 56 No. 4 (2014): Acta Médica Costarricense Octubre-Diciembre 2014

Section

Caso Clínico

License

Copyright (c) 2015 Acta Médica Costarricense

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)

How to Cite

First reported case of alloimmune fetal thrombocytopenia in primigravida. (2014). Acta Médica Costarricense , 56(4), 183-185. https://doi.org/10.51481/amc.v56i4.860 (Original work published 2015)